AMILOMOTIDE
UNII 31830Y299X

Substance Identification & Data

This profile provides standardized clinical and technical data for Amilomotide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 31830Y299X.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1238372-23-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

31830Y299X

CAS Registry Number

1238372-23-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

AMILOMOTIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C166623

National Cancer Institute reference terminology for clinical and research data.

INN ID

9490

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Amilomotide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

AMILOMOTIDE

Common Names & Synonyms

AMILOMOTIDE [INN]

REACTION PRODUCTS OF BACTERIOPHAGE Q-BETA COAT PROTEIN WITH HUMAN .BETA.-AMYLOID PROTEIN-(1-6)-PEPTIDYLGLYCYLGLYCYL-L-CYSTEINE AND 3-(2,5-DIOXO-2,5-DIHYDRO-1H-PYRROLE-1-YL)-N-(6-((2,5-DIOXOPYRROLIDIN-1-YL)OXY)-6-OXOHEXYL)PROPANAMIDE

VIRUS LIKE PARTICLE OF BACTERIOPHAGE Q-BETA COAT PROTEIN THAT IS COUPLED TO MULTIPLE COPIES OF HUMAN BETA-AMYLOID1-6 PEPTIDE FRAGMENT